Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

LEL

Lilly(Eli) (LEL)

Lilly(Eli)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:LEL
日付受信時刻ニュースソース見出しコード企業名
2014/01/3023 : 27PR Newswire (US)LILLY (ELI) & COMPANY - 4th Quarter EarningsLSE:LELLilly(Eli)
2013/07/2515 : 00PR Newswire (US)LILLY (ELI) & COMPANY - Half-yearly ReportLSE:LELLilly(Eli)
2013/07/0823 : 17PR Newswire (US)LILLY (ELI) & COMPANY - Form 8-KLSE:LELLilly(Eli)
2013/05/0823 : 06PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8K FilingLSE:LELLilly(Eli)
2013/05/0723 : 22PR Newswire (US)LILLY (ELI) & COMPANY - CEO Lechleiter to undergo surgeryLSE:LELLilly(Eli)
2013/05/0315 : 00PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementsLSE:LELLilly(Eli)
2013/05/0315 : 00PR Newswire (US)LILLY (ELI) & COMPANY - 1st Quarter ResultsLSE:LELLilly(Eli)
2013/04/2500 : 31PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8-K FilingLSE:LELLilly(Eli)
2013/03/2822 : 35UK RegulatoryLilly (Eli) & Co Cancellation of ListingLSE:LELLilly(Eli)
2013/03/2822 : 35PR Newswire (US)LILLY (ELI) & COMPANY - Cancellation of ListingLSE:LELLilly(Eli)
2013/03/2817 : 00UK RegulatoryOfficial List Cancellation Lilly (Eli) & CompanyLSE:LELLilly(Eli)
2013/03/2701 : 01PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementsLSE:LELLilly(Eli)
2013/03/2701 : 00PR Newswire (US)LILLY (ELI) & COMPANY - Statement re Intention to Cancel Listing of SharesLSE:LELLilly(Eli)
2013/02/2802 : 06PR Newswire (US)LILLY (ELI) & COMPANY - Statement re Intention to Cancel ListingLSE:LELLilly(Eli)
2013/02/0722 : 59PR Newswire (US)LILLY (ELI) & COMPANY - Phase 3 RA Program discontinued for TabalumabLSE:LELLilly(Eli)
2013/01/2922 : 33PR Newswire (US)LILLY (ELI) & COMPANY - Lilly Reports Q4 and Full-Year 2012 ResultsLSE:LELLilly(Eli)
2013/01/2503 : 24PR Newswire (US)LILLY (ELI) & COMPANY - Miscellaneous - Other SEC FilingsLSE:LELLilly(Eli)
2013/01/2503 : 22PR Newswire (US)LILLY (ELI) & COMPANY - Holding(s) in CompanyLSE:LELLilly(Eli)
2013/01/2503 : 21PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8-K FilingsLSE:LELLilly(Eli)
2013/01/2503 : 19PR Newswire (US)LILLY (ELI) & COMPANY - Director/PDMR ShareholdingLSE:LELLilly(Eli)
2013/01/2503 : 16PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementLSE:LELLilly(Eli)
2013/01/2503 : 15PR Newswire (US)LILLY (ELI) & COMPANY - 3rd Quarter ResultsLSE:LELLilly(Eli)
2013/01/2503 : 13PR Newswire (US)LILLY (ELI) & COMPANY - 1st Quarter ResultsLSE:LELLilly(Eli)
2013/01/2503 : 12PR Newswire (US)LILLY (ELI) & COMPANY - Half-yearly ReportLSE:LELLilly(Eli)
2013/01/2503 : 11PR Newswire (US)LILLY (ELI) & COMPANY - Annual Financial ReportLSE:LELLilly(Eli)
2013/01/2503 : 02PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2012LSE:LELLilly(Eli)
2013/01/2502 : 39PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2011LSE:LELLilly(Eli)
2013/01/2502 : 37PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2010LSE:LELLilly(Eli)
2013/01/1616 : 00PR Newswire (US)LILLY (ELI) & COMPANY - Amyvid Approved in European UnionLSE:LELLilly(Eli)
2013/01/0723 : 11PR Newswire (US)LILLY (ELI) & COMPANY - Phase III data results for empagliflozinLSE:LELLilly(Eli)
 Showing the most relevant articles for your search:LSE:LEL

最近閲覧した銘柄

Delayed Upgrade Clock